Display Settings:

Format

Send to:

Choose Destination

    PLoS Pathog. 2007 Feb;3(2):e17.

    A new inhibitor of apoptosis from vaccinia virus and eukaryotes.

    Gubser C, Bergamaschi D, Hollinshead M, Lu X, van Kuppeveld FJ, Smith GL.

    Department of Virology, Faculty of Medicine, Imperial College London, London, United Kingdom. c.gubser@imperial.ac.uk

    A new apoptosis inhibitor is described from vaccinia virus, camelpox virus, and eukaryotic cells. The inhibitor is a hydrophobic, multiple transmembrane protein that is resident in the Golgi and is named GAAP (Golgi anti-apoptotic protein). Stable expression of both viral GAAP (v-GAAP) and human GAAP (h-GAAP), which is expressed in all human tissues tested, inhibited apoptosis induced by intrinsic and extrinsic apoptotic stimuli. Conversely, knockout of h-GAAP by siRNA induced cell death by apoptosis. v-GAAP and h-GAAP display overlapping functions as shown by the ability of v-GAAP to complement for the loss of h-GAAP. Lastly, deletion of the v-GAAP gene from vaccinia virus did not affect virus replication in cell culture, but affected virus virulence in a murine infection model. This study identifies a new regulator of cell death that is highly conserved in evolution from plants to insects, amphibians, mammals, and poxviruses.

    PMID: 17319741 [PubMed - indexed for MEDLINE]

    PMCID: 1803007

    Supplemental Content

    Click here to read Click here to read Click here to read